EU Therapeutics Strategy: Commission presents a Therapeutics Innovation Booster to identify and support new treatments for COVID-19

24/05/2022 86 Views
EU Therapeutics Strategy: Commission presents a Therapeutics Innovation Booster to identify and support new treatments for COVID-19

Delivering on a key action from the EU Strategy on COVID-19 Therapeutics, the Commission has published yesterday the COVID-19 Therapeutics Innovation Booster, a report prepared by independent scientific experts. It facilitates the identification of promising research projects and technologies and provides guidance to researchers and innovators to best focus efforts and accelerate innovation. The guidance provided in this Booster is based on independent scientific advice, and focuses on facilitating the development of COVID-19 treatments that address the needs of patients as these evolve during the pandemic. It therefore supports efforts to bring safe and effective treatments to patients across the EU as fast as possible, as this remains a high priority in the transition towards the next phase of COVID-19.

Related articles